Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
about
Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulationThe RGS2 (-391, C>G) genetic variation correlates to antihypertensive drug responses in Chinese patients with essential hypertensionAn RGS4-mediated phenotypic switch of bronchial smooth muscle cells promotes fixed airway obstruction in asthmaRGS5 promotes arterial growth during arteriogenesisRegulation of GPCR signaling in hypertension.Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG.Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 alleleSensitivity and kinetics of signal transmission at the first visual synapse differentially impact visually-guided behavior.Regulator of G Protein Signaling 7 (RGS7) Can Exist in a Homo-oligomeric Form That Is Regulated by Gαo and R7-binding Protein.Microfabricated channel array electrophoresis for characterization and screening of enzymes using RGS-G protein interactions as a model system.Blood pressure and heart rate QTL in mice of the B6/D2 lineage: sex differences and environmental influences.Procontractile G protein-mediated signaling pathways antagonistically regulate smooth muscle differentiation in vascular remodeling.Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.Regulator of G protein signaling 4 inhibits human melanoma cells proliferation and invasion through the PI3K/AKT signaling pathway.Orphan receptor GPR37L1 contributes to the sexual dimorphism of central cardiovascular control.
P2860
Q28479035-233BB963-3A4D-466F-A671-F78D8040A75EQ28545858-0F2DF039-3555-498C-883B-BA6E4606DC33Q34130300-AB7A807E-A6FE-4077-B197-0A3C3B3CAA04Q34131192-1FE469B5-A2B8-44B5-9251-F33A1AA0CBADQ34273837-04E5ACF0-753B-48D3-B29F-657D9E75D93DQ34287867-1F247483-7CDE-493A-9BCB-DBE9DCC20F22Q34335443-7810FCCA-7638-4565-9B64-C94B98EE124BQ35071259-8B5B5EFD-EE25-4AA3-B282-29D8F632B303Q35545728-5FD789ED-577C-4805-B1CF-7EC18532B38CQ36884826-E0491E11-2B8E-4FA3-B71D-7634F67E2533Q37004104-6A09E8C0-E158-47F1-899A-EDD17B336DEDQ37106385-748DBD30-8C8C-4463-84F1-F851AEC8B607Q38320248-6559C15F-0A46-48CF-BE29-5673446445D2Q45070797-4FC68FC0-E2CF-4D51-8336-BBE33236E425Q47435317-2D1AF50C-E3B8-4CE7-B66E-D07F31DFD844Q52602004-3B1E6F9E-24B8-4DBC-981E-DC38DCB72B81
P2860
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
description
article
@en
im April 2003 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2003
@uk
name
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
@en
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
@nl
type
label
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
@en
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
@nl
prefLabel
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
@en
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
@nl
P2093
P356
P1476
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
@en
P2093
Anthony J Muslin
Antonio Oliveira-dos-Santos
J Michael Wyss
Kendall J Blumer
Kevin M Kaltenbronn
Robert P Mecham
Russell H Knutsen
Scott P Heximer
Thomas H Steinberg
P356
10.1172/JCI200315598A
P407
P577
2003-04-01T00:00:00Z